Bg pattern

FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet

Fungisdin 8.7 mg/ml cutaneous spray solution

Miconazole

Read this leaflet carefully before starting to use this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others, as it may harm them, even if their symptoms are the same as yours.

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What is Fungisdin and what is it used for
  2. Before using Fungisdin
  3. How to use Fungisdin
  4. Possible side effects
  5. Storage of Fungisdin
  6. Additional information

1. What is Fungisdin and what is it used for

Fungisdin contains the active ingredient miconazole, which belongs to a group of medicines called antifungals. Miconazole works by preventing the growth of fungi that cause infections.

Fungisdin is used to treat skin infections caused by dermatophytes, yeasts, and other fungi.

  • Dermatophyte infections such as: Tinea pedis (athlete's foot), T. corporis, T. cruris (marginated eczema of Hebra), T. manuum, T. unguium (onychomycosis), T. barbae.
  • Candidiasis such as: Intertrigo, perianal lesions, onychia and paronychia, angular stomatitis (perleche, cheilitis), balanoposthitis.
  • Fungal infections caused by various fungi such as: Pityriasis versicolor.

Fungisdin can be used to treat fungal infections that are superinfected with gram-positive bacteria sensitive to miconazole.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before using Fungisdin

Do not use Fungisdin

if you are allergic to the active ingredient, to other similar antifungals, or to any of the other components of this medicine (listed in section 6).

  • if you have liver problems;
  • if you have allergic asthma
  • if you are taking any of the following medicines (see section "Using Fungisdin with other medicines"):
    • some allergy medicines: terfenadine, astemizole, mizolastine;
    • cisapride, a medicine used to treat some digestive problems;
    • some cholesterol-lowering medicines, such as simvastatin and lovastatin;
    • midazolam administered orally and triazolam, medicines used for anxiety or to help you sleep (tranquilizers);
    • pimozide and sertindole, medicines used to treat diseases related to thought, feeling, and behavior disorders;
    • halofantrine, an antimalarial medicine;
    • some medicines used to treat migraine, such as ergot alkaloids: ergotamine, dihydroergotamine, ergometrine;
    • some medicines used to treat heart rhythm disorders: bepridil, quinidine, dofetilide;

Warnings and precautions

Consult your doctor or pharmacist before starting to use Fungisdin.

Fungisdin can cause severe allergic reactions. You should be aware of the signs of an allergic reaction when taking or administering this medicine (see section "Possible side effects").

Before applying Fungisdin, consider:

  • This medicine is for external use only. Do not ingest.
  • avoid contact with eyes, mucous membranes, and wounds
  • do not use on large areas. Use only on the affected area
  • do not apply Fungisdin to the same area where other medicines have been applied
  • due to its ethanol content, frequent application of the medicine may cause skin irritation and dryness.

Treatment should be discontinued if a sensitivity or irritation reaction occurs.

Using Fungisdin with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Some medicines may affect the way Fungisdin works or make it more likely to cause side effects. Fungisdin may also affect the way other medicines work.

If you are taking any of these medicines or others, consult your doctor or pharmacist before starting to use Fungisdin:

  • the anticoagulant medicine warfarin.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Using this medicine does not affect your ability to drive or operate machines.

3. How to use Fungisdin

Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.

Fungisdin is a medicine for external use only (on the skin).

The recommended dose is:

Apply a spray of the solution to the affected area 1 to 2 times a day and gently massage to facilitate penetration.

In case of nail infections, the nails should be cut as short as possible. Apply 1 or 2 times a day to the infected nail and surrounding area and cover with an occlusive dressing.

Wash your hands after each application.

If you use more Fungisdin than you should

Due to its external use (on the skin), it is unlikely to cause overdose episodes.

Symptomatic and supportive treatment will be applied. There is no known specific antidote for miconazole.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to use Fungisdin

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Fungisdin can cause side effects, although not everyone gets them.

Uncommon side effects

May affect up to 1 in 100 people:

Hypopigmentation (change in skin color)

Localized allergic reactions: inflammation, erythema (redness), urticaria, contact dermatitis, rash, pruritus (itching), burning sensation, irritation

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

.

5. Storage of Fungisdin

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Do not use Fungisdin after the expiration date stated on the packaging.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Package contents and additional information

Composition of Fungisdin

  • The active ingredient is miconazole. Each milliliter of Fungisdin contains 8.7 mg of miconazole.
  • The other ingredients are: Macrogolglycerides of capric/caprylic acid, Macrogol 300, Ethanol 99.8%

Appearance and packaging of the product

Fungisdin is presented in a 125 ml and 50 ml gas-free spray bottle.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Isdin SA

Provençals, 33

08019 Barcelona

Spain

Manufacturer:

TOWA Pharmaceutical Europe, S.L.

C/ de Sant Martí, 75-97

08107 Martorelles (Barcelona)

Spain

This leaflet was approved in June 2018

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/.

  • Country of registration
  • Average pharmacy price
    4.42 EUR
  • Availability in pharmacies
    Supply issue reported
    Data from the Spanish Agency of Medicines (AEMPS) indicates a supply issue affecting this medicine.<br><br>Availability may be limited in some pharmacies.<br><br>For updates or alternatives, consult your pharmacist.
  • Active substance
  • Prescription required
    Yes
  • Manufacturer
  • Alternatives to FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION
    Dosage form:  CREAM, 0.05 g betamethasone dipropionate; 1 g clotrimazole
    Active substance: 
    Manufacturer:  Teofarma S.R.L.
    Prescription required
    Dosage form:  CREAM, 20 mg/g + 10 mg/g
    Active substance:  miconazole, combinations
    Prescription required
    Dosage form:  CREAM, 1% bifonazole
    Active substance:  bifonazole
    Manufacturer:  Bayer Hispania S.L.
    Prescription required

Online doctors for FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION

Discuss questions about FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION?
FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION?
The active ingredient in FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION is miconazole. This information helps identify medicines with the same composition but different brand names.
How much does FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION cost in pharmacies?
The average pharmacy price for FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION is around 4.42 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION?
FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION is manufactured by Isdin S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FUNGISDIN 8.7 mg/ml CUTANEOUS SPRAY SOLUTION?
Other medicines with the same active substance (miconazole) include BETA-MICOTER 10 mg/g + 0.5 mg/g CREAM, BRENTÁN 20 MG/G + 10 MG/G CREAM, CANESMYCOSPOR 10 mg/g CREAM. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media